TBPH icon

Theravance Biopharma
TBPH

Overview Fund Activity

93 hedge funds and large institutions have $1.55B invested in Theravance Biopharma in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 31 increasing their positions, 21 reducing their positions, and 10 closing their positions.

Holders
93
Holders Change
+7
Holders Change %
+8.14%
% of All Funds
2.13%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
31
Reduced
21
Closed
10
Calls
$1.69M
Puts
$983K
Net Calls
+$702K
Net Calls Change
-$968K

Top Buyers

1
CCM
1
Consonance Capital Management
New York
$23.9M
2
WIM
2
Woodford Investment Management
United Kingdom
$382M
3
CS
3
Candriam SCA
Luxembourg
$8.32M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$120M
5
Millennium Management
5
Millennium Management
New York
$4.3M

Top Sellers

1
AC
1
Armistice Capital
New York
$0
2
First Manhattan
2
First Manhattan
New York
$0
3
CAM
3
Cormorant Asset Management
Massachusetts
$35.9M
4
BNP Paribas Asset Management
4
BNP Paribas Asset Management
France
$0
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$52.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
S
101
SignatureFD
Georgia
– -$5K -200 Closed
1 2 3 4
5